...
首页> 外文期刊>The Australian and New Zealand journal of psychiatry >Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: Findings of the third national survey on use of psychotropic medications in China
【24h】

Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: Findings of the third national survey on use of psychotropic medications in China

机译:中国精神分裂症患者的抗精神来心多药片及其与治疗满意度与生活与生活的关联:中国三国使用的第三次调查

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: This study examined the use, demographic and clinical correlates of antipsychotic polypharmacy (APP) and its associations with treatment satisfaction and quality of life (QOL) in schizophrenia patients in China.
机译:目的:本研究检测了抗精神分离症多野营(APP)及其与中国精神分裂症患者治疗满意度和生活质量(QOL)的使用,人口和临床关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号